HGH Fragment 176-191 & CJC-1295 & Ipamorelin Blend (12mg) – Triple-Action Research Peptide

Welcome to Liaocheng Yixin Company, your trusted source for premium hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research. As a specialized peptide synthesis manufacturer operating from our facility at No. 9 Lushan Road, Dongcheng Street, Liaocheng Economic and Technological Development Zone, Shandong Province, we provide high-quality research compounds for the global scientific community.

This 12mg triple blend combines HGH Fragment 176-191, CJC-1295 (No DAC)

• hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research

, and Ipamorelin into a single research formulation. Each component targets a distinct pathway within the growth hormone axis, allowing investigators to study the interplay between upstream signaling and downstream metabolic effects. Our hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research offers a convenient, precisely formulated tool for metabolic and endocrine studies .

What is the Fragment 176-191, CJC-1295 & Ipamorelin Blend?

This 12mg lyophilized blend contains three research peptides that work through complementary mechanisms:

Component Profile:

HGH Fragment 176-191 is a synthetic peptide corresponding to the C-terminal region of human growth hormone, hypothesized to target adipose tissues for lipolytic research. CJC-1295 (No DAC) is a tetrasubstituted GHRH analog with enhanced stability. Ipamorelin is a selective growth hormone secretagogue known for its ability to stimulate GH release without substantially impacting cortisol or prolactin levels .

• hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research

Mechanism of Action in Research

Each component of the blend targets a distinct but interconnected pathway:

HGH Fragment 176-191 – Lipolytic Signaling

HGH Fragment 176-191 is hypothesized to influence lipid metabolism through selective targeting of adipocytes. Research suggests the fragment stimulates hormone-sensitive lipase in fat cells, breaking stored triglycerides into free fatty acids while inhibiting lipogenesis . Importantly, it does not activate the GH receptor or increase IGF-1 levels, making it valuable for studying fat metabolism independently of systemic growth hormone effects .

CJC-1295 – Extended GHRH Signaling

CJC-1295 is a synthetic analog of growth hormone-releasing hormone designed to resist rapid degradation and support prolonged GHRH receptor interaction. As a temporal amplifier, it may extend signal duration rather than increase signal intensity, offering researchers a tool to explore sustained upstream stimulation of the growth hormone axis .

Ipamorelin – Selective Ghrelin Receptor Agonism

Ipamorelin is a ghrelin-mimetic that interacts with the growth hormone secretagogue receptor (GHS-R1a). Its reputed selectivity allows it to preferentially engage somatotropic signaling pathways while exhibiting minimal interaction with other ghrelin-associated systems, making it valuable for receptor bias studies .

Synergistic Modulation

This blend’s research rationale lies in complementarity: Fragment 176-191 influences downstream metabolic signaling related to lipid handling, while CJC-1295 and Ipamorelin shape upstream growth hormone release dynamics. This vertical integration—modulating both signal generation and downstream specificity—may reveal emergent properties not observable when each peptide is studied in isolation .

• hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research

Scientific Research Applications

Metabolic Research

This triple blend is studied in adipose tissue metabolism research, body composition models, and lipid mobilization investigations. The combination allows researchers to explore how upstream GH modulation interacts with targeted lipolytic effects of Fragment 176-191 .

Endocrine Dynamics Research

Investigators use the blend to examine how combined GH secretagogues affect IGF-1 concentrations, insulin sensitivity, and anabolic signaling pathways . The dual GHRH pathway approach provides tools for exploring both short-acting and sustained elevation patterns .

Pharmacokinetic and Pharmacodynamic Studies

The differing half-lives and receptor selectivities of the three components support comparative research into combined GH secretagogue therapies and pharmacokinetic modeling .

Why Choose Liaocheng Yixin Company?

When sourcing hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Certificates of Analysis confirming purity exceeding 99% are available upon request .

Research-Grade Specifications

• Components: HGH Fragment 176-191, CJC-1295 (No DAC), Ipamorelin

• Total Mass: 12mg lyophilized powder

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed container, protected from light and moisture

• Form: Lyophilized powder for research use

• hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

6. hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research

: What research applications use this triple blend?

A: The blend is used in metabolic research (adipose tissue metabolism, body composition), endocrine dynamics studies, pharmacokinetic and pharmacodynamic research, and investigations of synergistic GH pathway interactions .

: How does this blend differ from dual blends?

A: Dual blends typically combine only two peptides (e.g., CJC-1295 + Ipamorelin). This triple blend adds HGH Fragment 176-191, providing a targeted lipolytic research component alongside upstream GH modulation from the two growth hormone secretagogues .

: What is the rationale for combining these three peptides?

A: The rationale is based on complementarity rather than redundancy. Fragment 176-191 influences downstream metabolic signaling, while CJC-1295 and Ipamorelin shape upstream growth hormone release. This vertical integration may reveal emergent properties not observable when each peptide is studied in isolation .

: What purity level can I expect?

A: All batches are tested to ensure ≥99% purity by HPLC analysis. Certificates of Analysis are available upon request.

: Is this product for human use?

A: No. This triple blend is manufactured strictly for research use only (RUO). It is not intended for human consumption or clinical applications .

When you need premium hgh fragment 176-191 cjc-1295 ipamorelin blend 12mg for research for your metabolic, endocrine, or pharmacokinetic studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.